Skip to main content
FinSpry Logo
FinSpry
CRSP logo
CRSP
(NASDAQ)
CRISPR Therapeutics AG
$55.79-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CRISPR Therapeutics (CRSP) Stock Price & Financial Analysis

CRISPR Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$55.35 - $57.21
52-Week High$78.48
52-Week Low$44.12
Open$56.06
Volume893.78K
Average Volume (3M)1.45M
Market Cap5.36B
Shares Outstanding96.05M
Price to Sales (P/S)1306.04
Price to Book (P/B)2.95
EV/EBITDA-9.22
Revenue (TTM)4.10M
Net Income (TTM)-593.30M
Free Cash Flow (TTM)-401.18M
EPS (TTM)$-6.42
Profit Margin-14460.13%
Operating Margin-15754.20%
Return on Equity (ROE)-32.70%
Debt to Equity0.33
50-Day MA$53.76
200-Day MA$53.24
52-Week Change1.70%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About CRISPR Therapeutics

What is the current stock price for CRSP?

As of the latest trading session, CRSP stock trades at $55.79. The 52-week range is $44.12–$78.48, with a day range of $55.35–$57.21.

What is the P/E ratio for CRSP?

The P/E ratio (Price-to-Earnings) for CRSP is shown in the Key Statistics section. This valuation metric helps compare CRISPR Therapeutics AG to industry peers.

Does CRSP pay dividends?

CRISPR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRSP?

Based on 7 analysts, the consensus for CRSP is Buy.

What is the market cap of CRSP?

CRISPR Therapeutics's market capitalization is $5.36B, classifying it as a mid-cap company. CRISPR Therapeutics operates in the Healthcare sector within the Biotechnology industry.